ClassID:

110376

C12N2740/15032 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:
#1
20260117234
2026-04-30

GENE SEQUENCE CONSTRUCT USED FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

#2
20250388929
2025-12-25

Retroviral and Lentiviral Vectors

#3
20250122533
2025-04-17

VIRAL VECTORS AND PACKAGING CELL LINES

#4
20250122532
2025-04-17

VIRAL VECTORS AND PACKAGING CELL LINES

#5
20240252681
2024-08-01

GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS

#6
20240167034
2024-05-23

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS

#7
20240093232
2024-03-21

Retroviral And Lentiviral Vectors

#8
20230346835
2023-11-02

CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA AND USE THEREOF

#9
20230338407
2023-10-26

COMPOSITIONS AND METHODS OF TREATMENT USING NICOTINAMIDE MONONUCLEOTIDE

#10
20230285591
2023-09-14

NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE

#11
20230212568
2023-07-06

MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS

#12
20230190961
2023-06-22

COMPOSITIONS AND METHODS FOR TREATING MYELIN DEFICIENCY BY REJUVENATING GLIAL PROGENITOR CELLS

#13
20230133695
2023-05-04

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS

#14
20220177919
2022-06-09

CYBB LENTIVIRAL VECTOR, LENTIVIRAL VECTOR-TRANSDUCED STEM CELL, AND PREPARATION METHOD AND APPLICATION THEREOF

#15
20220016203
2022-01-20

COMPOSITIONS AND METHODS FOR PREVENTION AND REDUCTION OF METASTASIS

#16
20210348191
2021-11-11

Retroviral and lentiviral vectors

#17
20210147871
2021-05-20

Viral vectors and packaging cell lines

#18
20200318137
2020-10-08

TRAIL-SECRETING MESENCHYMAL STEM CELLS AND USE THEREOF TO TREAT BRAIN TUMORS

#19
20200215087
2020-07-09

Compositions and methods of treatment using nicotinamide mononucleotide

#20
20200087682
2020-03-19

Compositions and methods for treating phenylketonuria

#21
20190177746
2019-06-13

Retroviral and lentiviral vectors

#22
20190125898
2019-05-02

Nipah virus envelope pseudotyped lentiviruses and methods of their use

#23
20190076458
2019-03-14

METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

#24
20180223313
2018-08-09

Lentiviral protein delivery system for RNA-guided genome editing

#25
20180066280
2018-03-08

Retroviral and lentiviral vectors

#26
20170296677
2017-10-19

Nipah virus envelope pseudotyped lentiviruses and methods of their use

#27
20170252402
2017-09-07

METHODS FOR TREATING TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA WITH APOLIPOPROTEIN D

#28
20170175135
2017-06-22

Virus Purification

#29
20170114324
2017-04-27

Pluripotent cell lines and methods of use thereof

#30
20170096684
2017-04-06

Lentiviral vectors

#31
20170073702
2017-03-16

Virus purification

#32
20160074532
2016-03-17

METHODS AND COMPOSITIONS FOR ATTENUATING GENE EDITING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

#33
20160074531
2016-03-17

METHODS AND COMPOSITIONS FOR ATTENUATING GENE THERAPY ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

#34
20160074372
2016-03-17

Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses

#35
20160067228
2016-03-10

Methods and compositions for attenuating anti-viral transfer vector immune responses

#36
20150352181
2015-12-10

Methods for treating tissue damage associated with ischemia with apolipoprotein D

#37
20150343038
2015-12-03

METHOD AND COMPOSITION FOR TREATING SPASTICITY

#38
20150050242
2015-02-19

Nipah virus envelope pseudotyped lentiviruses and methods of their use

#39
20100167286
2010-07-01

Pluripotent cell lines and methods of use thereof

#40
20080124308
2008-05-29

Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins